Reckitt Benckiser Group plc Key Executives
This section highlights Reckitt Benckiser Group plc's key executives, including their titles and compensation details.
Find Contacts at Reckitt Benckiser Group plc
(Showing 0 of )
Reckitt Benckiser Group plc Earnings
This section highlights Reckitt Benckiser Group plc's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-03-07 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-10-23 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-07-24 | $0.39 | $1.61 |
| Read Transcript | Q1 | 2024 | 2024-04-24 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-02-29 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-26 | $0.43 | $1.72 |
| Read Transcript | Q1 | 2023 | 2023-04-29 | N/A | N/A |
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
$13.45
Stock Price
$46.22B
Market Cap
-
Employees
Slough, None
Location
Financial Statements
Access annual & quarterly financial statements for Reckitt Benckiser Group plc, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $14.61B | $14.45B | $13.23B | $13.99B | $12.85B |
| Cost of Revenue | $5.85B | $6.09B | $5.56B | $5.56B | $5.07B |
| Gross Profit | $8.76B | $8.36B | $7.68B | $8.44B | $7.78B |
| Gross Profit Ratio | 59.97% | 57.85% | 58.00% | 60.28% | 60.55% |
| Research and Development Expenses | $337.00M | $325.00M | $313.00M | $288.00M | $257.00M |
| General and Administrative Expenses | $1.38B | $1.21B | $1.19B | $1.39B | $740.00M |
| Selling and Marketing Expenses | $3.70B | $3.44B | $3.46B | $3.61B | $3.42B |
| Selling General and Administrative Expenses | $5.08B | $4.64B | $4.65B | $5.00B | $4.16B |
| Other Expenses | $807.00M | $158.00M | $-1.00M | $-2.00M | $202.00M |
| Operating Expenses | $6.23B | $5.13B | $4.96B | $5.29B | $4.62B |
| Cost and Expenses | $12.08B | $11.22B | $10.52B | $10.85B | $9.68B |
| Interest Income | $6.00M | $29.00M | $29.00M | $77.00M | $161.00M |
| Interest Expense | $295.00M | $257.00M | $244.00M | $363.00M | $314.00M |
| Depreciation and Amortization | $470.00M | $604.00M | $429.00M | $470.00M | $436.00M |
| EBITDA | $3.17B | $3.90B | $465.00M | $3.61B | $3.78B |
| EBITDA Ratio | 21.67% | 27.23% | 29.99% | 32.89% | 29.89% |
| Operating Income | $2.53B | $3.25B | $3.49B | $3.15B | $-1.71B |
| Operating Income Ratio | 17.33% | 22.48% | 26.36% | 22.48% | -13.34% |
| Total Other Income Expenses Net | $-130.00M | $-182.00M | $544.00M | $-1.27B | $-153.00M |
| Income Before Tax | $2.40B | $3.07B | $-260.00M | $1.87B | $-2.11B |
| Income Before Tax Ratio | 16.44% | 21.22% | -1.96% | 13.39% | -16.40% |
| Income Tax Expense | $753.00M | $711.00M | $-208.00M | $720.00M | $665.00M |
| Net Income | $1.64B | $2.33B | $-52.00M | $1.19B | $-2.77B |
| Net Income Ratio | 11.25% | 16.12% | -0.39% | 8.48% | -21.58% |
| EPS | $2.27 | $3.27 | $-0.07 | $1.67 | $-3.91 |
| EPS Diluted | $2.29 | $3.26 | $-0.07 | $1.66 | $-3.91 |
| Weighted Average Shares Outstanding | 722.52M | 715.28M | 713.76M | 710.91M | 708.69M |
| Weighted Average Shares Outstanding Diluted | 718.28M | 717.49M | 713.76M | 713.75M | 708.69M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 | December 31, 2014 | June 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.17B | $7.16B | $7.45B | $7.57B | $6.89B | $6.64B | $6.60B | $7.08B | $6.91B | $6.61B | $6.24B | $6.14B | $6.46B | $4.98B | $5.09B | $4.39B | $4.52B | $4.36B | $4.51B | $4.32B |
| Cost of Revenue | $2.83B | $2.84B | $3.04B | $3.22B | $2.91B | $2.80B | $2.82B | $2.90B | $2.74B | $2.63B | $2.52B | $2.43B | $2.49B | $1.98B | $1.94B | $1.74B | $1.78B | $1.84B | $1.87B | $1.87B |
| Gross Profit | $4.34B | $4.32B | $4.41B | $4.35B | $3.98B | $3.84B | $3.78B | $4.18B | $4.17B | $3.98B | $3.72B | $3.71B | $3.98B | $3.00B | $3.16B | $2.64B | $2.73B | $2.51B | $2.64B | $2.45B |
| Gross Profit Ratio | 60.57% | 60.40% | 59.20% | 57.50% | 57.80% | 57.90% | 57.20% | 59.08% | 60.35% | 60.25% | 59.57% | 60.44% | 61.55% | 60.25% | 61.97% | 60.28% | 60.54% | 57.64% | 58.59% | 56.72% |
| Research and Development Expenses | $- | $168.50M | $- | $- | $- | $156.50M | $- | $144.00M | $- | $- | $- | $- | $187.00M | $- | $149.00M | $- | $140.00M | $- | $146.00M | $- |
| General and Administrative Expenses | $- | $706.00M | $- | $- | $- | $595.00M | $- | $696.50M | $- | $- | $- | $- | $724.00M | $- | $636.00M | $- | $575.00M | $- | $528.00M | $- |
| Selling and Marketing Expenses | $- | $1.85B | $- | $- | $- | $1.73B | $- | $1.81B | $- | $- | $- | $- | $2.95B | $- | $2.38B | $- | $2.17B | $- | $2.25B | $- |
| Selling General and Administrative Expenses | $2.65B | $2.74B | $2.66B | $2.84B | $2.25B | $2.17B | $2.40B | $2.62B | $2.52B | $2.13B | $2.28B | $2.42B | $1.75B | $1.94B | $1.09B | $1.94B | $1.19B | $1.56B | $1.21B | $1.57B |
| Other Expenses | $13.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Operating Expenses | $2.66B | $2.74B | $2.66B | $2.84B | $2.25B | $2.17B | $2.40B | $2.62B | $2.52B | $2.13B | $2.28B | $2.42B | $2.34B | $1.96B | $1.60B | $1.94B | $1.45B | $1.57B | $1.35B | $1.60B |
| Cost and Expenses | $5.49B | $5.58B | $5.69B | $6.06B | $5.16B | $4.96B | $5.23B | $5.52B | $5.26B | $4.75B | $4.80B | $4.85B | $4.82B | $3.94B | $3.54B | $3.68B | $3.23B | $3.42B | $3.22B | $3.47B |
| Interest Income | $68.00M | $9.00M | $42.00M | $44.00M | $51.00M | $49.50M | $57.50M | $37.00M | $70.50M | $110.00M | $72.00M | $180.00M | $158.00M | $24.00M | $2.00M | $11.00M | $2.00M | $18.00M | $1.00M | $18.00M |
| Interest Expense | $388.00M | $182.00M | $158.00M | $172.00M | $- | $- | $- | $- | $- | $119.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $237.00M | $246.00M | $234.00M | $384.00M | $223.00M | $265.00M | $216.00M | $242.00M | $230.00M | $224.00M | $214.00M | $196.00M | $104.00M | $93.00M | $62.00M | $80.00M | $78.00M | $78.00M | $82.00M | $79.00M |
| EBITDA | $1.92B | $813.00M | $994.50M | $1.89B | $985.00M | $730.50M | $793.50M | $800.00M | $942.50M | $2.08B | $810.00M | $1.49B | $2.15B | $1.16B | $1.98B | $788.00M | $1.49B | $1.03B | $1.38B | $957.00M |
| EBITDA Ratio | 26.72% | 25.58% | 26.70% | 24.96% | 28.37% | 29.20% | 24.05% | 25.53% | 27.28% | 31.41% | 26.43% | 24.23% | 33.32% | 23.19% | 38.95% | 17.97% | 33.00% | 23.67% | 30.60% | 22.14% |
| Operating Income | $1.68B | $1.59B | $1.75B | $1.50B | $1.73B | $1.67B | $1.37B | $1.57B | $1.66B | $1.85B | $1.44B | $1.29B | $2.05B | $1.06B | $1.92B | $708.00M | $1.41B | $953.00M | $1.30B | $878.00M |
| Operating Income Ratio | 23.41% | 22.15% | 23.56% | 19.88% | 25.13% | 25.21% | 20.78% | 22.11% | 23.95% | 28.02% | 23.00% | 21.03% | 31.71% | 21.33% | 37.73% | 16.14% | 31.27% | 21.88% | 28.78% | 20.31% |
| Total Other Income Expenses Net | $-160.00M | $-823.00M | $-935.00M | $-128.00M | $-885.50M | $-831.00M | $-3.31B | $-1.13B | $-936.00M | $-5.22B | $-804.00M | $-180.00M | $-191.00M | $-47.00M | $-5.00M | $-11.00M | $-15.00M | $-32.00M | $-20.00M | $-40.00M |
| Income Before Tax | $1.52B | $763.00M | $1.64B | $1.38B | $1.69B | $1.69B | $-1.94B | $436.00M | $1.44B | $-3.37B | $1.26B | $1.11B | $1.48B | $1.02B | $1.56B | $697.00M | $1.29B | $921.00M | $1.29B | $838.00M |
| Income Before Tax Ratio | 21.18% | 10.65% | 22.00% | 18.19% | 24.58% | 25.41% | -29.45% | 6.16% | 20.81% | -51.00% | 20.22% | 18.10% | 22.94% | 20.39% | 30.55% | 15.89% | 28.49% | 21.14% | 28.54% | 19.38% |
| Income Tax Expense | $374.00M | $358.00M | $395.00M | $376.00M | $335.00M | $-17.00M | $-191.00M | $321.00M | $399.00M | $394.00M | $271.00M | $232.00M | $1.13B | $232.00M | $309.00M | $211.00M | $251.00M | $212.00M | $281.00M | $181.00M |
| Net Income | $1.14B | $402.00M | $1.23B | $991.00M | $1.35B | $1.69B | $-1.73B | $112.00M | $1.07B | $-3.79B | $112.00M | $867.00M | $2.60B | $777.00M | $1.25B | $484.00M | $1.03B | $709.00M | $1.01B | $657.00M |
| Net Income Ratio | 15.93% | 5.61% | 16.55% | 13.10% | 19.54% | 25.51% | -26.14% | 1.58% | 15.55% | -57.45% | 1.79% | 14.13% | 40.20% | 15.59% | 24.44% | 11.04% | 22.89% | 16.28% | 22.29% | 15.20% |
| EPS | $1.61 | $0.56 | $1.72 | $1.38 | $1.88 | $2.37 | $-2.42 | $0.16 | $1.51 | $-5.35 | $0.16 | $1.22 | $3.66 | $1.10 | $1.74 | $0.68 | $1.44 | $0.98 | $1.38 | $0.90 |
| EPS Diluted | $1.61 | $0.56 | $1.72 | $1.38 | $1.88 | $2.37 | $-2.42 | $0.15 | $1.51 | $-5.35 | $0.16 | $1.22 | $3.66 | $1.10 | $1.74 | $0.68 | $1.44 | $0.98 | $1.38 | $0.90 |
| Weighted Average Shares Outstanding | 709.32M | 717.32M | 716.50M | 715.76M | 714.90M | 714.41M | 713.70M | 712.74M | 710.20M | 709.75M | 708.03M | 709.49M | 711.47M | 710.89M | 711.65M | 717.04M | 719.94M | 727.18M | 730.44M | 730.81M |
| Weighted Average Shares Outstanding Diluted | 709.30M | 718.85M | 718.10M | 718.71M | 716.60M | 714.41M | 713.70M | 725.94M | 712.50M | 709.75M | 709.91M | 709.66M | 711.40M | 710.85M | 712.00M | 716.60M | 720.06M | 727.03M | 730.35M | 731.13M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.16B | $1.16B | $1.26B | $1.65B | $1.55B |
| Short Term Investments | $229.00M | $- | $-1.00M | $-19.00M | $-155.00M |
| Cash and Short Term Investments | $1.39B | $1.16B | $1.26B | $1.65B | $1.55B |
| Net Receivables | $1.71B | $1.72B | $1.55B | $1.56B | $1.72B |
| Inventory | $1.64B | $1.82B | $1.46B | $1.59B | $1.31B |
| Other Current Assets | $573.00M | $579.00M | $734.00M | $519.00M | $454.00M |
| Total Current Assets | $5.30B | $5.29B | $5.00B | $5.31B | $5.03B |
| Property Plant Equipment Net | $2.40B | $2.47B | $2.18B | $2.23B | $2.14B |
| Goodwill | $4.58B | $5.61B | $5.33B | $5.37B | $6.46B |
| Intangible Assets | $14.01B | $14.59B | $13.54B | $17.61B | $17.80B |
| Goodwill and Intangible Assets | $18.59B | $20.20B | $18.87B | $22.98B | $24.26B |
| Long Term Investments | $118.00M | $86.00M | $195.00M | $155.00M | $213.00M |
| Tax Assets | $- | $244.00M | $197.00M | $258.00M | $224.00M |
| Other Non-Current Assets | $729.00M | $451.00M | $503.00M | $353.00M | $268.00M |
| Total Non-Current Assets | $21.83B | $23.46B | $21.94B | $25.98B | $27.11B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $27.14B | $28.74B | $26.95B | $31.29B | $32.14B |
| Account Payables | $2.19B | $2.37B | $2.06B | $1.83B | $1.40B |
| Short Term Debt | $1.68B | $1.72B | $2.48B | $763.00M | $3.65B |
| Tax Payables | $742.00M | $791.00M | $93.00M | $72.00M | $145.00M |
| Deferred Revenue | $620.00M | $- | $- | $- | $- |
| Other Current Liabilities | $3.10B | $3.46B | $3.45B | $4.27B | $3.73B |
| Total Current Liabilities | $8.34B | $8.34B | $8.09B | $6.94B | $8.93B |
| Long Term Debt | $6.86B | $7.41B | $7.15B | $9.79B | $8.54B |
| Deferred Revenue Non-Current | $- | $- | $1.19B | $1.44B | $1.38B |
| Deferred Tax Liabilities Non-Current | $- | $3.04B | $2.81B | $3.56B | $3.51B |
| Other Non-Current Liabilities | $3.47B | $3.51B | $3.07B | $3.96B | $3.88B |
| Total Non-Current Liabilities | $10.33B | $10.92B | $11.40B | $15.20B | $13.80B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $18.67B | $19.26B | $19.49B | $22.13B | $22.73B |
| Preferred Stock | $- | $294.00M | $1.19B | $379.00M | $80.00M |
| Common Stock | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M |
| Retained Earnings | $23.41B | $23.64B | $22.49B | $23.40B | $23.35B |
| Accumulated Other Comprehensive Income Loss | $- | $-294.00M | $-1.19B | $-379.00M | $-80.00M |
| Other Total Stockholders Equity | $-15.04B | $-13.97B | $-16.35B | $-13.98B | $-13.98B |
| Total Stockholders Equity | $8.45B | $9.44B | $7.40B | $9.12B | $9.36B |
| Total Equity | $8.47B | $9.48B | $7.45B | $9.16B | $9.41B |
| Total Liabilities and Stockholders Equity | $27.14B | $28.74B | $26.95B | $31.29B | $32.14B |
| Minority Interest | $21.00M | $40.00M | $54.00M | $44.00M | $44.00M |
| Total Liabilities and Total Equity | $27.14B | $28.74B | $26.95B | $31.29B | $32.14B |
| Total Investments | $118.00M | $86.00M | $194.00M | $136.00M | $58.00M |
| Total Debt | $8.54B | $8.88B | $9.56B | $10.56B | $12.20B |
| Net Debt | $7.38B | $7.73B | $8.30B | $8.91B | $10.65B |
Balance Sheet Charts
| Breakdown | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 | December 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $986.00M | $1.39B | $1.03B | $1.16B | $1.29B | $1.26B | $1.48B | $1.65B | $2.56B | $1.55B | $1.71B | $1.48B | $1.54B | $2.12B | $2.46B | $882.00M | $894.00M | $740.00M | $666.00M | $917.00M |
| Short Term Investments | $-18.00M | $- | $-193.00M | $- | $-178.00M | $-1.00M | $-157.00M | $-19.00M | $25.42B | $-155.00M | $30.64B | $- | $11.00M | $18.00M | $1.00M | $3.00M | $126.00M | $121.00M | $13.00M | $1.00M |
| Cash and Short Term Investments | $986.00M | $1.39B | $1.03B | $1.16B | $1.29B | $1.26B | $1.48B | $1.65B | $2.56B | $1.55B | $1.71B | $1.48B | $1.55B | $2.14B | $2.46B | $885.00M | $1.02B | $740.00M | $679.00M | $918.00M |
| Net Receivables | $2.18B | $1.71B | $2.17B | $1.72B | $2.20B | $1.55B | $1.77B | $1.56B | $1.94B | $1.72B | $2.07B | $1.83B | $1.94B | $1.72B | $1.85B | $1.46B | $1.38B | $1.16B | $1.21B | $1.04B |
| Inventory | $1.58B | $1.64B | $1.66B | $1.82B | $1.80B | $1.46B | $1.48B | $1.59B | $1.52B | $1.31B | $1.33B | $1.28B | $1.26B | $1.20B | $1.32B | $770.00M | $752.00M | $681.00M | $707.00M | $745.00M |
| Other Current Assets | $136.00M | $573.00M | $143.00M | $579.00M | $265.00M | $734.00M | $2.05B | $519.00M | $165.00M | $454.00M | $142.00M | $358.00M | $138.00M | $375.00M | $226.00M | $339.00M | $333.00M | $297.00M | $74.00M | $461.00M |
| Total Current Assets | $4.88B | $5.30B | $5.00B | $5.29B | $5.55B | $5.00B | $6.77B | $5.31B | $6.18B | $5.03B | $5.26B | $4.95B | $4.88B | $5.42B | $5.86B | $3.45B | $3.48B | $2.88B | $2.67B | $3.16B |
| Property Plant Equipment Net | $2.33B | $2.40B | $2.36B | $2.47B | $2.33B | $2.18B | $2.08B | $2.23B | $2.21B | $2.14B | $2.18B | $1.86B | $1.76B | $1.75B | $1.81B | $878.00M | $819.00M | $730.00M | $723.00M | $757.00M |
| Goodwill | $- | $4.58B | $- | $5.61B | $- | $5.33B | $5.01B | $5.37B | $- | $6.46B | $- | $11.83B | $- | $11.50B | $- | $3.92B | $3.60B | $3.28B | $- | $3.26B |
| Intangible Assets | $18.42B | $14.01B | $19.36B | $14.59B | $20.28B | $13.54B | $13.03B | $17.61B | $25.38B | $17.80B | $30.58B | $18.45B | $29.68B | $17.99B | $30.14B | $9.53B | $9.12B | $8.01B | $10.96B | $7.99B |
| Goodwill and Intangible Assets | $18.42B | $18.59B | $19.36B | $20.20B | $20.28B | $18.87B | $18.04B | $22.98B | $25.38B | $24.26B | $30.58B | $30.28B | $29.68B | $29.49B | $30.14B | $13.45B | $12.72B | $11.30B | $10.96B | $11.25B |
| Long Term Investments | $146.00M | $240.00M | $272.00M | $86.00M | $295.00M | $195.00M | $315.00M | $155.00M | $-25.38B | $213.00M | $-30.58B | $53.00M | $43.00M | $23.00M | $41.00M | $36.00M | $- | $- | $-12.00M | $- |
| Tax Assets | $- | $287.00M | $240.00M | $244.00M | $222.00M | $197.00M | $243.00M | $258.00M | $245.00M | $224.00M | $182.00M | $209.00M | $191.00M | $118.00M | $38.00M | $81.00M | $80.00M | $57.00M | $50.00M | $61.00M |
| Other Non-Current Assets | $629.00M | $320.00M | $281.00M | $451.00M | $324.00M | $503.00M | $277.00M | $353.00M | $25.79B | $268.00M | $30.95B | $300.00M | $232.00M | $207.00M | $137.00M | $120.00M | $133.00M | $303.00M | $270.00M | $266.00M |
| Total Non-Current Assets | $21.52B | $21.83B | $22.52B | $23.46B | $23.45B | $21.94B | $20.96B | $25.98B | $28.25B | $27.11B | $33.32B | $32.70B | $31.91B | $31.59B | $32.16B | $14.57B | $13.75B | $12.39B | $12.00B | $12.34B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $26.41B | $27.14B | $27.52B | $28.74B | $29.01B | $26.95B | $27.73B | $31.29B | $34.43B | $32.14B | $38.58B | $37.65B | $36.78B | $37.01B | $38.02B | $18.02B | $17.23B | $15.27B | $14.66B | $15.50B |
| Account Payables | $5.12B | $2.19B | $4.98B | $2.37B | $5.33B | $2.06B | $4.98B | $1.83B | $5.61B | $1.40B | $5.96B | $1.80B | $4.66B | $1.71B | $4.78B | $1.24B | $3.40B | $981.00M | $2.95B | $990.00M |
| Short Term Debt | $1.07B | $1.68B | $3.37B | $1.72B | $2.20B | $2.48B | $3.58B | $763.00M | $1.61B | $3.65B | $2.77B | $2.29B | $1.95B | $1.12B | $1.20B | $1.58B | $2.04B | $1.75B | $1.82B | $1.94B |
| Tax Payables | $651.00M | $620.00M | $623.00M | $791.00M | $156.00M | $93.00M | $80.00M | $72.00M | $41.00M | $145.00M | $6.00M | $133.00M | $19.00M | $230.00M | $29.00M | $133.00M | $44.00M | $188.00M | $160.00M | $288.00M |
| Deferred Revenue | $- | $620.00M | $- | $- | $- | $- | $80.00M | $236.00M | $41.00M | $-2.75B | $6.00M | $133.00M | $19.00M | $230.00M | $29.00M | $133.00M | $44.00M | $188.00M | $160.00M | $288.00M |
| Other Current Liabilities | $205.00M | $3.85B | $292.00M | $3.46B | $249.00M | $3.45B | $729.00M | $4.27B | $215.00M | $3.73B | $254.00M | $3.40B | $583.00M | $3.06B | $804.00M | $2.31B | $588.00M | $1.93B | $362.00M | $1.79B |
| Total Current Liabilities | $7.04B | $8.34B | $9.26B | $8.34B | $7.94B | $8.09B | $9.36B | $6.94B | $7.47B | $8.93B | $8.99B | $7.61B | $7.22B | $6.58B | $6.82B | $5.40B | $6.07B | $5.04B | $5.29B | $5.29B |
| Long Term Debt | $7.83B | $7.04B | $5.27B | $7.41B | $7.72B | $7.15B | $7.06B | $9.79B | $11.20B | $8.54B | $9.89B | $9.95B | $10.36B | $11.53B | $16.03B | $804.00M | $749.00M | $671.00M | $630.00M | $636.00M |
| Deferred Revenue Non-Current | $- | $249.00M | $544.00M | $- | $- | $1.19B | $1.34B | $1.44B | $1.58B | $1.38B | $1.52B | $1.51B | $1.49B | $1.50B | $1.72B | $1.27B | $1.23B | $931.00M | $772.00M | $911.00M |
| Deferred Tax Liabilities Non-Current | $- | $2.90B | $2.92B | $3.04B | $3.00B | $2.81B | $3.00B | $3.56B | $3.77B | $3.51B | $3.58B | $3.62B | $3.54B | $3.44B | $4.99B | $1.98B | $1.85B | $1.69B | $1.69B | $1.75B |
| Other Non-Current Liabilities | $3.45B | $3.28B | $3.23B | $3.51B | $4.37B | $3.07B | $3.37B | $3.96B | $4.16B | $3.88B | $3.71B | $5.30B | $3.93B | $3.84B | $5.19B | $2.11B | $1.98B | $1.72B | $1.73B | $1.83B |
| Total Non-Current Liabilities | $11.28B | $10.33B | $9.04B | $10.92B | $12.10B | $11.40B | $11.78B | $15.20B | $16.93B | $13.80B | $15.12B | $15.25B | $15.77B | $16.86B | $22.94B | $4.19B | $3.96B | $3.32B | $3.13B | $3.37B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $18.32B | $18.67B | $18.31B | $19.26B | $20.03B | $19.49B | $21.14B | $22.13B | $24.41B | $22.73B | $24.11B | $22.86B | $22.99B | $23.44B | $29.75B | $9.59B | $10.03B | $8.36B | $8.42B | $8.66B |
| Preferred Stock | $- | $- | $897.00M | $294.00M | $295.00M | $1.19B | $611.00M | $379.00M | $- | $80.00M | $- | $13.79B | $13.95B | $13.82B | $13.86B | $13.71B | $14.21B | $15.18B | $15.38B | $15.05B |
| Common Stock | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M | $74.00M |
| Retained Earnings | $23.26B | $9.18B | $23.98B | $23.64B | $23.12B | $22.49B | $21.06B | $23.40B | $23.70B | $23.35B | $27.62B | $28.21B | $27.38B | $27.04B | $21.77B | $21.81B | $21.09B | $21.76B | $21.30B | $21.56B |
| Accumulated Other Comprehensive Income Loss | $- | $-1.06B | $-897.00M | $-294.00M | $-295.00M | $-1.19B | $-611.00M | $-379.00M | $181.00M | $-80.00M | $719.00M | $-13.79B | $-13.95B | $-13.82B | $-13.86B | $-13.71B | $-14.21B | $-15.18B | $-15.38B | $-15.05B |
| Other Total Stockholders Equity | $-15.26B | $-15.04B | $-14.87B | $-13.97B | $-13.98B | $-16.35B | $-13.98B | $-13.98B | $-13.80B | $-13.98B | $-13.27B | $-27.36B | $-27.65B | $-27.40B | $-27.48B | $-27.17B | $-28.18B | $-30.11B | $-30.52B | $-29.86B |
| Total Stockholders Equity | $8.07B | $8.45B | $9.19B | $9.44B | $8.93B | $7.40B | $6.55B | $9.12B | $9.97B | $9.36B | $14.43B | $14.74B | $13.75B | $13.53B | $8.23B | $8.42B | $7.20B | $6.90B | $6.24B | $6.83B |
| Total Equity | $8.09B | $8.47B | $9.21B | $9.48B | $8.97B | $7.45B | $6.58B | $9.16B | $10.02B | $9.41B | $14.47B | $14.79B | $13.79B | $13.57B | $8.27B | $8.43B | $7.20B | $6.91B | $6.24B | $6.83B |
| Total Liabilities and Stockholders Equity | $26.41B | $27.14B | $27.52B | $28.74B | $29.01B | $26.95B | $27.73B | $31.29B | $34.43B | $32.14B | $38.58B | $37.65B | $36.78B | $37.01B | $38.02B | $18.02B | $17.23B | $15.27B | $14.66B | $15.50B |
| Minority Interest | $23.00M | $21.00M | $21.00M | $40.00M | $47.00M | $54.00M | $31.00M | $44.00M | $46.00M | $44.00M | $44.00M | $47.00M | $41.00M | $40.00M | $39.00M | $5.00M | $4.00M | $2.00M | $2.00M | $2.00M |
| Total Liabilities and Total Equity | $26.41B | $27.14B | $27.52B | $28.74B | $29.01B | $26.95B | $27.73B | $31.29B | $34.43B | $32.14B | $38.58B | $37.65B | $36.78B | $37.01B | $38.02B | $18.02B | $17.23B | $15.27B | $14.66B | $15.50B |
| Total Investments | $128.00M | $240.00M | $79.00M | $86.00M | $117.00M | $194.00M | $158.00M | $136.00M | $49.00M | $58.00M | $54.00M | $53.00M | $54.00M | $41.00M | $42.00M | $39.00M | $126.00M | $121.00M | $1.00M | $1.00M |
| Total Debt | $8.90B | $8.54B | $8.64B | $8.88B | $9.73B | $9.56B | $10.60B | $10.56B | $12.81B | $12.20B | $12.31B | $11.88B | $12.29B | $12.86B | $17.23B | $2.39B | $2.79B | $2.42B | $2.45B | $2.57B |
| Net Debt | $7.91B | $7.15B | $7.62B | $7.73B | $8.44B | $8.30B | $9.12B | $8.91B | $10.25B | $10.65B | $10.60B | $10.40B | $10.74B | $10.74B | $14.77B | $1.51B | $1.89B | $1.68B | $1.78B | $1.66B |
Annual Cash Flow
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Net Income | $2.40B | $3.07B | $-804.00M | $2.16B | $-1.95B |
| Depreciation and Amortization | $470.00M | $607.00M | $481.00M | $1.46B | $5.55B |
| Deferred Income Tax | $- | $- | $- | $- | $- |
| Stock Based Compensation | $102.00M | $78.00M | $30.00M | $15.00M | $18.00M |
| Change in Working Capital | $-60.00M | $-422.00M | $-313.00M | $922.00M | $-206.00M |
| Accounts Receivables | $-87.00M | $-23.00M | $-130.00M | $94.00M | $-150.00M |
| Inventory | $118.00M | $-254.00M | $-57.00M | $-317.00M | $-87.00M |
| Accounts Payables | $-91.00M | $-145.00M | $-126.00M | $1.15B | $31.00M |
| Other Working Capital | $- | $- | $- | $- | $- |
| Other Non Cash Items | $-277.00M | $-933.00M | $2.30B | $-1.04B | $-2.00B |
| Net Cash Provided by Operating Activities | $2.64B | $2.40B | $1.70B | $3.52B | $1.41B |
| Investments in Property Plant and Equipment | $-348.00M | $-443.00M | $-450.00M | $-486.00M | $-443.00M |
| Acquisitions Net | $-81.00M | $-12.00M | $-942.00M | $10.00M | $-18.00M |
| Purchases of Investments | $- | $- | $-27.00M | $-36.00M | $-18.00M |
| Sales Maturities of Investments | $- | $- | $77.00M | $-10.00M | $137.00M |
| Other Investing Activities | $-37.00M | $316.00M | $1.58B | $10.00M | $-100.00M |
| Net Cash Used for Investing Activities | $-466.00M | $-139.00M | $239.00M | $-512.00M | $-442.00M |
| Debt Repayment | $-217.00M | $-1.53B | $-1.01B | $-1.68B | $426.00M |
| Common Stock Issued | $46.00M | $54.00M | $80.00M | $131.00M | $61.00M |
| Common Stock Repurchased | $-207.00M | $- | $-5.00M | $-4.00M | $- |
| Dividends Paid | $-1.34B | $-1.25B | $-1.25B | $-1.24B | $-1.23B |
| Other Financing Activities | $-92.00M | $348.00M | $-109.00M | $-63.00M | $-90.00M |
| Net Cash Used Provided by Financing Activities | $-1.81B | $-2.38B | $-2.29B | $-2.86B | $-830.00M |
| Effect of Forex Changes on Cash | $-137.00M | $19.00M | $-35.00M | $-52.00M | $-69.00M |
| Net Change in Cash | $224.00M | $-103.00M | $-385.00M | $97.00M | $70.00M |
| Cash at End of Period | $1.38B | $1.16B | $1.26B | $1.64B | $1.55B |
| Cash at Beginning of Period | $1.16B | $1.26B | $1.64B | $1.55B | $1.48B |
| Operating Cash Flow | $2.64B | $2.40B | $1.70B | $3.52B | $1.41B |
| Capital Expenditure | $-449.00M | $-443.00M | $-450.00M | $-486.00M | $-443.00M |
| Free Cash Flow | $2.19B | $1.95B | $1.25B | $3.03B | $968.00M |
Cash Flow Charts
| Breakdown | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 | December 31, 2014 | June 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.14B | $402.00M | $1.23B | $991.00M | $1.35B | $1.69B | $-1.75B | $110.00M | $1.03B | $-3.76B | $979.00M | $860.00M | $2.83B | $252.50M | $1.31B | $526.00M | $1.03B | $709.00M | $2.41B | $812.00M |
| Depreciation and Amortization | $237.00M | $246.00M | $234.00M | $384.00M | $223.00M | $265.00M | $216.00M | $242.00M | $230.00M | $224.00M | $214.00M | $196.00M | $52.00M | $46.50M | $62.00M | $80.00M | $78.00M | $78.00M | $82.00M | $79.00M |
| Deferred Income Tax | $- | $-89.50M | $-981.50M | $- | $-1.05B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $39.00M | $30.50M | $20.50M | $- | $13.50M | $5.50M | $9.50M | $-2.00M | $9.50M | $- | $17.50M | $38.00M | $21.00M | $18.00M | $33.00M | $33.00M | $25.00M | $25.00M | $29.00M | $26.00M |
| Change in Working Capital | $-153.00M | $433.00M | $-493.00M | $171.00M | $-593.00M | $51.00M | $-364.00M | $184.00M | $738.00M | $-80.00M | $-126.00M | $12.00M | $-151.00M | $-8.00M | $-166.00M | $153.00M | $-176.00M | $-20.00M | $-92.00M | $-120.00M |
| Accounts Receivables | $-180.00M | $76.00M | $-163.00M | $135.00M | $-158.00M | $-173.00M | $43.00M | $-72.00M | $166.00M | $-144.00M | $-6.00M | $74.00M | $-111.50M | $6.50M | $-182.00M | $157.00M | $-191.00M | $-27.00M | $-65.00M | $-103.00M |
| Inventory | $27.00M | $24.00M | $94.00M | $-41.00M | $-213.00M | $41.00M | $-98.00M | $-149.00M | $-168.00M | $-44.00M | $-43.00M | $-62.00M | $-39.50M | $-14.50M | $16.00M | $-4.00M | $15.00M | $7.00M | $-27.00M | $-17.00M |
| Accounts Payables | $-748.00M | $333.00M | $-424.00M | $77.00M | $-222.00M | $183.00M | $-309.00M | $405.00M | $740.00M | $108.00M | $-77.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $748.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non Cash Items | $-283.00M | $679.00M | $923.00M | $611.00M | $900.00M | $-543.00M | $3.41B | $1.25B | $-239.00M | $4.47B | $579.00M | $14.00M | $-2.20B | $385.00M | $-12.00M | $407.00M | $31.00M | $- | $-1.14B | $12.00M |
| Net Cash Provided by Operating Activities | $982.00M | $1.70B | $935.00M | $1.56B | $837.00M | $985.00M | $712.00M | $1.48B | $2.03B | $319.00M | $1.09B | $1.12B | $551.50M | $694.00M | $1.22B | $1.20B | $992.00M | $792.00M | $1.29B | $809.00M |
| Investments in Property Plant and Equipment | $-126.00M | $-260.00M | $-189.00M | $-268.00M | $-175.00M | $-263.00M | $-187.00M | $-340.00M | $-146.00M | $-262.00M | $-181.00M | $-139.00M | $-97.50M | $-45.50M | $-114.00M | $-62.00M | $-88.00M | $-66.00M | $-98.00M | $-59.00M |
| Acquisitions Net | $- | $-21.00M | $4.00M | $260.00M | $59.00M | $860.00M | $-144.00M | $6.00M | $4.00M | $18.00M | $1.00M | $- | $15.50M | $-5.92B | $-116.00M | $-42.00M | $-3.00M | $-7.00M | $-26.00M | $-314.00M |
| Purchases of Investments | $- | $- | $- | $- | $- | $-6.00M | $-21.00M | $-36.00M | $- | $-11.00M | $-7.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $20.00M | $1.00M | $-1.00M | $-244.00M | $229.00M | $-252.00M | $252.00M | $-45.00M | $-14.00M | $- | $-18.50M | $-37.00M | $1.60B | $500.00K | $55.00M | $-304.00M | $12.00M | $18.00M | $-196.00M | $-22.00M |
| Net Cash Used for Investing Activities | $-106.00M | $-280.00M | $-186.00M | $-252.00M | $113.00M | $339.00M | $-100.00M | $-370.00M | $-142.00M | $-255.00M | $-187.00M | $-176.00M | $1.52B | $-5.97B | $-175.00M | $-408.00M | $-79.00M | $-55.00M | $-320.00M | $-395.00M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $15.00M | $33.00M | $17.00M | $37.00M | $23.00M | $57.00M | $83.00M | $48.00M | $28.00M | $33.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-765.00M | $-209.00M | $- | $- | $- | $-5.00M | $- | $-4.00M | $- | $- | $- | $- | $- | $- | $-402.00M | $-400.00M | $-352.00M | $-452.00M | $-290.00M | $-23.00M |
| Dividends Paid | $-820.00M | $-549.00M | $-790.00M | $-523.00M | $-726.00M | $-521.00M | $-725.00M | $-520.00M | $-721.00M | $-518.00M | $-709.00M | $-688.00M | $-234.00M | $-333.00M | $-410.00M | $-625.00M | $-358.00M | $-566.00M | $-434.00M | $-554.00M |
| Other Financing Activities | $347.00M | $131.50M | $25.00M | $-885.00M | $240.00M | $-285.50M | $-305.50M | $-451.00M | $265.50M | $386.00M | $11.00M | $-775.00M | $-1.97B | $6.41B | $-263.00M | $334.00M | $-121.00M | $51.00M | $-37.00M | $144.00M |
| Net Cash Used Provided by Financing Activities | $-1.24B | $-1.04B | $-765.00M | $-1.41B | $-972.00M | $-1.62B | $-668.00M | $-1.95B | $-911.00M | $-132.00M | $-698.00M | $-1.46B | $-2.21B | $6.08B | $-1.07B | $-691.00M | $-831.00M | $-967.00M | $-761.00M | $-433.00M |
| Effect of Forex Changes on Cash | $-35.00M | $-11.50M | $-57.00M | $-29.00M | $24.00M | $-2.50M | $-15.00M | $-39.00M | $13.00M | $- | $12.00M | $-64.00M | $-26.50M | $-17.50M | $8.00M | $55.00M | $5.00M | $-33.00M | $-13.00M | $-69.00M |
| Net Change in Cash | $-401.00M | $360.00M | $-130.00M | $-129.00M | $25.00M | $-217.00M | $-168.00M | $-911.00M | $994.00M | $-68.00M | $219.00M | $-291.50M | $-160.50M | $782.50M | $-9.50M | $77.50M | $43.50M | $-131.50M | $98.00M | $-44.00M |
| Cash at End of Period | $986.00M | $1.39B | $1.03B | $1.16B | $1.29B | $1.26B | $1.48B | $1.65B | $2.56B | $1.55B | $1.71B | $1.53B | $-160.50M | $782.50M | $-9.50M | $892.00M | $43.50M | $650.00M | $98.00M | $717.00M |
| Cash at Beginning of Period | $1.39B | $1.03B | $1.16B | $1.29B | $1.26B | $1.48B | $1.65B | $2.56B | $1.56B | $1.62B | $1.49B | $1.83B | $- | $- | $- | $814.50M | $- | $781.50M | $- | $761.00M |
| Operating Cash Flow | $982.00M | $1.70B | $935.00M | $1.56B | $837.00M | $985.00M | $712.00M | $1.48B | $2.03B | $319.00M | $1.09B | $1.12B | $551.50M | $694.00M | $1.22B | $1.20B | $992.00M | $792.00M | $1.29B | $809.00M |
| Capital Expenditure | $-126.00M | $-260.00M | $-189.00M | $-268.00M | $-175.00M | $-263.00M | $-187.00M | $-340.00M | $-146.00M | $-262.00M | $-181.00M | $-139.00M | $-97.50M | $-45.50M | $-114.00M | $-62.00M | $-88.00M | $-66.00M | $-98.00M | $-59.00M |
| Free Cash Flow | $856.00M | $1.44B | $746.00M | $1.29B | $662.00M | $722.00M | $525.00M | $1.14B | $1.89B | $57.00M | $911.00M | $981.00M | $454.00M | $648.50M | $1.11B | $1.14B | $904.00M | $726.00M | $1.19B | $750.00M |
Reckitt Benckiser Group plc Dividends
Explore Reckitt Benckiser Group plc's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
3.42%
Dividend Payout Ratio
81.50%
Dividend Paid & Capex Coverage Ratio
1.47x
Reckitt Benckiser Group plc Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.29 | $0.29 | April 11, 2025 | April 11, 2025 | June 05, 2025 | March 14, 2025 |
| $0.208 | $0.208 | August 05, 2024 | August 05, 2024 | September 23, 2024 | July 24, 2024 |
| $0.294 | $0.294 | April 11, 2024 | April 12, 2024 | June 03, 2024 | February 28, 2024 |
| $0.198 | $0.198 | August 04, 2023 | August 07, 2023 | September 22, 2023 | July 26, 2023 |
| $0.265 | $0.265 | April 10, 2023 | April 11, 2023 | June 01, 2023 | March 01, 2023 |
| $0.176 | $0.176 | August 05, 2022 | August 08, 2022 | September 21, 2022 | July 27, 2022 |
| $0.267 | $0.267 | April 28, 2022 | April 29, 2022 | June 16, 2022 | March 11, 2022 |
| $0.186 | $0.202 | August 05, 2021 | August 06, 2021 | September 22, 2021 | July 27, 2021 |
| $0.2861 | $0.279 | May 06, 2021 | May 07, 2021 | June 21, 2021 | April 14, 2021 |
| $0.1873 | $0.191 | August 20, 2020 | August 21, 2020 | October 06, 2020 | July 31, 2020 |
| $0.2501 | $0.254 | April 16, 2020 | April 17, 2020 | June 04, 2020 | April 14, 2020 |
| $0.1792 | $0.178 | August 22, 2019 | August 23, 2019 | October 03, 2019 | |
| $0.2532 | $0.264 | April 22, 2019 | April 23, 2019 | May 31, 2019 | |
| $0.1844 | $0.185 | August 16, 2018 | August 17, 2018 | October 04, 2018 | July 30, 2018 |
| $0.2612 | $0.273 | April 12, 2018 | April 13, 2018 | June 01, 2018 | |
| $0.1737 | $0.174 | August 16, 2017 | August 18, 2017 | October 05, 2017 | July 25, 2017 |
| $0.2457 | $0.236 | April 13, 2017 | April 18, 2017 | June 02, 2017 | June 29, 2016 |
| $0.1508 | $0.155 | August 17, 2016 | August 19, 2016 | October 06, 2016 | |
| $0.2599 | $0.253 | April 13, 2016 | April 15, 2016 | June 03, 2016 | |
| $0.1523 | $0.157 | August 12, 2015 | August 14, 2015 | October 02, 2015 |
Reckitt Benckiser Group plc News
Read the latest news about Reckitt Benckiser Group plc, including recent articles, headlines, and updates.
Reckitt Benckiser Group plc (RBGPF) Q4 2024 Earnings Call Transcript
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q4 2024 Earnings Conference Call March 6, 2025 3:30 AM ET Company Participants Nick Ashworth - Head of Investor Relations Kris Licht - Chief Executive Officer Shannon Eisenhardt - Chief Financial Officer Conference Call Participants Rashad Kawan - Morgan Stanley Chris Pitcher - Redburn Atlantic David Hayes - Jefferies Jeremy Fialko - HSBC Harold Thompson - Chelverton James Edwards Jones - RBC Iain Simpson - Barclays Callum Elliott - Bernstein Nick Ashworth Good morning, everybody and thank you for joining us for the Reckitt Full-year 2024 Results Presentation. For those of you that don't know me, I'm Nick Ashworth and I head up Investor Relations here at Reckitt.
Reckitt Benckiser ups dividend as profit slips on reshuffle
Reckitt Benckiser Group PLC has upped its dividend after a drop in profit last year as efforts continued to revamp the consumer goods business. Operating profit fell 4.2% to £2.43 billion in the year to December 31, as revenue slipped 3.0% to £14.17 billion on an international financial reporting standards basis.
An Investigation Has Been Launched Into Reckitt Benckiser Group plc For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or "the Company") (OTC PINK:RBGLY) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses In Reckitt Benckiser Group plc To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or "the Company") (OTC PINK:RBGLY) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Levi & Korsinsky Announces an Investigation on Behalf of Reckitt Benckiser Group plc (RBGLY) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt Benckiser Group plc Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - RBGLY
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt Benckiser Group plc Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - RBGLY
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt Benckiser Group plc Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - RBGLY
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Reckitt Benckiser Group plc (RBGLY)
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
An Investigation Has Commenced on Behalf of Reckitt Benckiser Group plc Shareholders. Contact Levi & Korsinsky to Discuss your RBGLY Losses
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt Benckiser Group: New Bull Run Initiated
Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high-growth, high-margin brands and potential divestitures could drive future revenue and earnings growth, despite current sales declines. The company's dividend history is strong, with a 22-year streak of no cuts, but future increases are likely modest due to a high payout ratio.
Did Reckitt Benckiser Group plc Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - RBGLY
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt Benckiser Group plc (RBGLY) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Reckitt transformation the focus in results as ‘execution risks' loom
Reckitt Benckiser Group PLC faced a tough review from Barclays analysts ahead of its full-year results on Thursday, 6 March, as the bank flagged “execution risks”. Bumping the consumer goods firm from an ‘overweight' to ‘equal weight' rating in February, Barclays cautioned over plans to transform its portfolio.
Reckitt Benckiser Group plc INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Reckitt Benckiser Group plc (RBGLY)
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
ATTENTION RBGLY SHAREHOLDERS: Investors who lost money on Reckitt Benckiser Group plc are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
ATTENTION Reckitt Benckiser Group plc Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESS Newswire / February 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
An Investigation Has Commenced on Behalf of Reckitt Benckiser Group plc Shareholders. Contact Levi & Korsinsky to Discuss your RBGLY Losses.
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC PINK:RBGLY) concerning possible violations of federal securities laws. An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for RBGLY.